TKT and renal carcinoma: Consistent with the above findings, ectopic overexpression of PKM2 in renal carcinoma cells with stable TKT knockdown effectively rescued the inhibitory effects of TKT deficiency on both metastatic (Supplementary Fig. S2A) and proliferative capacity (Supplementary Fig. S2B, C) potential.